We are live on ! Find out more
GEHC icon

GE HealthCare

64.25 USD
+0.32
0.5%
At close Updated Sep 14, 4:00 PM EDT
Pre-market
After hours
64.98
+0.73
1.14%
1 day
0.5%
5 days
-5.45%
1 month
-12.81%
3 months
-0.79%
6 months
-10.97%
Year to date
-22.42%
1 year
-17.37%
5 years
7.08%
10 years
7.08%
 

About: GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).

Employees: 54,000

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 38.8%
Neutral 56.7%
Negative 4.5%
Positive
Reuters
1 day ago
GE HealthCare in talks over possible $1 billion deal for Sofie Biosciences, FT reports
GE HealthCare Technologies is in talks ​over a possible $1 billion deal to ‌buy radiopharmaceutical developer Sofie Biosciences, the Financial Times reported on Sunday citing people familiar ​with the matter.
GE HealthCare in talks over possible $1 billion deal for Sofie Biosciences, FT reports
Neutral
Seeking Alpha
5 days ago
GE HealthCare Technologies Inc. (GEHC) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
GE HealthCare Technologies Inc. (GEHC) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
GE HealthCare Technologies Inc. (GEHC) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Neutral
Zacks Investment Research
5 days ago
GE HealthCare Moves StarGuide GX 4D SPECT/CT Toward FDA Clearance
GEHC moves StarGuide GX closer to the U.S. market with an FDA 510(k) submission, advancing its next-generation molecular imaging push.
GE HealthCare Moves StarGuide GX 4D SPECT/CT Toward FDA Clearance
Neutral
Business Wire
6 days ago
GE HealthCare aims to advance a new era in theranostics with StarGuide™ GX 4D SPECT/CT, now 510(k) pending with the U.S. FDA
CHICAGO--(BUSINESS WIRE)--GE HealthCare today announced that StarGuide GX,i its new digital 4D CZT SPECT/CT technology, is 510(k) pending with the U.S. Food and Drug Administration (FDA). Building on the system's recent CE Mark, this milestone is a step towards expanding access to advanced molecular imaging technologies in the United States and marks a significant moment in molecular imaging's evolution – aiming to empower clinicians with a high-performance, general purpose scanner to help pers.
GE HealthCare aims to advance a new era in theranostics with StarGuide™ GX 4D SPECT/CT, now 510(k) pending with the U.S. FDA
Positive
Zacks Investment Research
12 days ago
GEHC Wins CE Mark for Photonova Spectra, Expands International Reach
GE HealthCare's Photonova Spectra gains CE Mark, expanding access to its Deep Silicon photon-counting CT technology across Europe and other CE markets.
GEHC Wins CE Mark for Photonova Spectra, Expands International Reach
Positive
Zacks Investment Research
14 days ago
GEHC vs. HAE: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Products stocks have likely encountered both GE HealthCare Technologies (GEHC) and Haemonetics (HAE). But which of these two stocks is more attractive to value investors?
GEHC vs. HAE: Which Stock Is the Better Value Option?
Positive
Zacks Investment Research
14 days ago
GE HealthCare Unveils Next-Gen Vivid Cardiac Ultrasound Systems
GEHC expands its Vivid cardiovascular ultrasound portfolio with three systems featuring AI tools and cSound imaging for varied care settings.
GE HealthCare Unveils Next-Gen Vivid Cardiac Ultrasound Systems
Neutral
Business Wire
14 days ago
GE HealthCare's Photonova™ Spectra gains CE Mark, expanding international access
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) recently achieved CE Mark for Photonova Spectra,i an advanced photon-counting computed tomography (PCCT) system with the company's proprietary Deep Silicon™ detector technology. The regulatory milestone expands access and enables clinical adoption of the technology in CE Mark–observing countries and underscores GE HealthCare's commitment to purposeful, customer-driven innovation in computed tomography (CT). “We are proud to deliver this new.
GE HealthCare's Photonova™ Spectra gains CE Mark, expanding international access
Positive
Zacks Investment Research
17 days ago
Why Is GE HealthCare (GEHC) Up 3.6% Since Last Earnings Report?
GE HealthCare (GEHC) reported earnings 30 days ago. What's next for the stock?
Why Is GE HealthCare (GEHC) Up 3.6% Since Last Earnings Report?
Neutral
Business Wire
17 days ago
GE HealthCare unveils the next generation of the Vivid cardiovascular ultrasound portfolio, enabling advanced cardiac imaging across care settings
CHICAGO--(BUSINESS WIRE)--GE HealthCare today announced three additions to its Vivid™ cardiovascular ultrasound portfolio – Vivid™ Explorer, Vivid™ Advanced and Vivid™ Focus.
GE HealthCare unveils the next generation of the Vivid cardiovascular ultrasound portfolio, enabling advanced cardiac imaging across care settings
Price charts implemented using Lightweight Charts™